The MATN3 gene helps make matrilin-3, a protein that supports cartilage in growing bones and joints. If it does not work properly, cartilage may not form as it should, and some people develop joint pain, early osteoarthritis, short stature, or a skeletal condition such as multiple epiphyseal dysplasia. Differences in this gene can help explain why people in the same family share similar bone and joint problems, especially during childhood and early adult life.
What is a gene?
Genes are segments of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes hold the directions for making proteins, the parts of cells that do the work. Others mainly help determine when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and functions, and they can shape how you respond to food, stress, or medications. To explore this topic in more detail, you can find more in the LearnHub.
Overview
MATN3Gene function
What if the gene works
The MATN3 gene helps make matrilin 3, a protein that supports cartilage, the smooth, firm tissue in joints and growing bones. This helps bones develop with stable shape and cushioning.
Risk
What if the gene does not work
Variants in the MATN3 gene most often cause multiple epiphyseal dysplasia, affecting bone growth and joints, with short stature, joint pain, and early osteoarthritis. Milder and more severe variants can affect when symptoms start and joint involvement.
Treatment
What does that mean for your treatment
No MATN3-specific treatment or management approach is currently established. The MATN3 gene is being studied in cartilage and osteoarthritis research, but this does not currently guide drug choice or targeted therapy.
Conditions associated with MATN3
Gene function
What if the gene works
This gene helps build the smooth, springy material that cushions joints and supports growing bones. In cartilage, the MATN3 gene gives cells instructions for matrilin-3, a protein released into the space around cells. It helps organize the cartilage matrix, the supportive material that gives cartilage its strength and flexibility.
The MATN3 gene helps cartilage cells place matrilin-3 into the matrix around them. This protein becomes part of the supportive mesh that gives cartilage its spring and structure.
Matrilin-3 acts like a connector between other cartilage proteins, helping them line up into a stable network. This supports cartilage development and joint cushioning during everyday movement.
In growing bones, matrilin-3 helps keep growth plate cartilage organized. That organized cartilage helps bones lengthen in a steady, controlled way during childhood and adolescence.
Healthy cartilage needs the right mix of strength and flexibility. MATN3 supports the matrix that helps joint surfaces stay smooth as they absorb repeated pressure.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the MATN3 gene often make the matrilin-3 protein fold incorrectly, so less of it reaches the cartilage outside the cell. This explains how MATN3 gene variants affect cartilage protein structure and release. Some changes have milder effects, with partial loss of protein function, while more disruptive variants can cause a larger drop in working protein and are linked to earlier or more marked bone and joint changes, including multiple epiphyseal dysplasia.
How variants are linked to conditions
Pathogenic variants in the MATN3 gene are linked to multiple epiphyseal dysplasia, a condition that affects bone ends and joints during growth and often leads to joint pain, a waddling walk, or early osteoarthritis. Some variants in the MATN3 gene are also linked to a rarer bone growth condition called spondyloepimetaphyseal dysplasia, which can affect the spine as well as the limbs. In a person with these features, a disease-causing variant in the MATN3 gene can help confirm the diagnosis.
A variant is not necessarily a diagnosis
Gene variants are a routine part of human biology and are widespread in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors are involved. In some cases, though, one well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that clearly increase or reduce health risk related to the MATN3 gene itself. In families with a disease-causing MATN3 change, the main factor is whether that variant is present, while symptoms can still vary from person to person.
Inheritance of MATN3 variants
How MATN3 gene variants are inherited depends on the specific MATN3 related condition. The best known MATN3 related skeletal condition, multiple epiphyseal dysplasia, is usually inherited in an autosomal dominant pattern, so a parent carrying the variant has a 50% chance of passing it to each child. Some other MATN3 related conditions are inherited in an autosomal recessive pattern, which means a child must inherit one altered copy from each parent. MATN3 is on chromosome 2, an autosome, so these variants can be passed to children of any sex.
What does my MATN3 result mean for my family?
MATN3 results can mean different things for family members depending on the condition linked to the variant. Some MATN3 changes are passed in a dominant way, so a parent, child, brother, or sister may also carry the same change and may want to learn whether it affects them. Other MATN3 changes are linked to a recessive condition, which means relatives may be healthy carriers without symptoms.
Genetic information
Genetic testing
How you find out about variants
MATN3 variants are found with a genetic test, usually from a blood sample or saliva sample. A lab reads the MATN3 gene to look for changes that can explain inherited cartilage and bone growth conditions. MATN3 genetic testing can confirm whether a known disease-causing variant is present.
When should I consider getting a genetic test?
Testing for the MATN3 gene may be considered if a child or adult has joint pain, stiffness, mild short stature, or X-ray findings that suggest multiple epiphyseal dysplasia, a condition that affects bone growth and joints. It can also help when similar problems run in the family.
A genetic result is only one part of your health story
Genetic findings can provide meaningful insight, but how much they reveal varies by the condition and the type of variant involved. Over time, many other factors also shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results may also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or responds to a drug. This helps explain why the same treatment works well for one person, has little effect in another, or causes more side effects in someone else. These differences are common and are one of several reasons medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences can affect how people respond to medicines. By looking at links between genes and medications, it helps explain why the same treatment may work differently in different people. With many drugs, genes can influence either how powerfully a medicine works or how the body handles it. This understanding can support treatment decisions that are better informed and more individualized. To explore this subject further, more information is available in the LearnHub.
Drugs influenced by the MATN3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so general health concerns or questions about side effects, new symptoms, or medication changes are best discussed with your doctor.